Conor McNamara
Head of Investor Relations
Replay available
Illumina, Inc. (NASDAQ: ILMN) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Jefferies
Analyst, Evercore ISI
Analyst, RBC Capital Markets
Analyst, Bank of America
Analyst, Guggenheim
Analyst, Canaccord Genuity
Analyst, Oberon Research
Analyst, J.P. Morgan
Good day, ladies and gentlemen. Welcome to the second quarter 2026 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we will conduct a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the call over to Head of Investor Relations, Conor McNamara. Hello, everyone, and welcome to Illumina's second quarter 2026 Earnings Call. Today, we will review our financial results released after market close and provide prepared remarks before opening the line for questions and answers. Our earnings release is available in the investor relations section of Illumina.com. Joining me today are Jacob Thaysen, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer. Jacob will begin with an update on Illumina's business, followed by Ankur's review of the financials. We will be discussing certain non-GAAP financial measures, and a reconciliation to GAAP can be found in today's release and in the supplementary data on our website. Unless otherwise stated, all growth rates are presented on a year-over-year reported basis. Organic growth adjusts for the impact of currency and acquisitions, and rest-of-world organic growth also excludes greater China due to our inclusion on China's unreliable entity list. This call is being recorded, and the replay will be available on our website. It is our intent that all forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the documents that Illumina files with the SEC, including our most recent Forms 10Q and 10K. With that...